Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Akcea Therapeutics Inc. AKCA

Healthcare Biotechnology
Akcea Therapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. It is advancing a mature pipeline of novel drugs with the potential to treat multiple diseases. The company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are... see more

Recent & Breaking News (NDAQ:AKCA)

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product

PR Newswire October 30, 2020

Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics

PR Newswire October 12, 2020

SHAREHOLDER ALERT: Monteverde & Associates Is Investigating the Merger

ACCESSWIRE IA October 2, 2020

IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm - AKCA, BLDR, DCOM, STND

PR Newswire September 26, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA, IMMU, and MXIM Shareholders About Its Ongoing Investigations

PR Newswire September 25, 2020

SHAREHOLDER ALERT: Monteverde & Associates Continues Investigating the Merger

ACCESSWIRE IA September 25, 2020

Lifshitz Law Firm, P.C. Announces Investigation of Akcea Therapeutics, Inc. (NASDAQ: AKCA), BMC Stock Holdings, Inc. (NASDAQ: BMCH), Builders FirstSource, Inc. (NASDAQ: BLDR), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Otelco Inc. (NASDAQ: OTEL), Rosetta Stone Inc. (NYSE: RST), Varian Medical Systems, Inc. (NYSE: VAR), and Yintech Investment Holdings Limited (NASDAQ: YIN)

PR Newswire September 25, 2020

STOCKHOLDER ALERT: Monteverde & Associates Continues its Investigation into the Following Merger

ACCESSWIRE IA September 23, 2020

SHAREHOLDER ALERT: Halper Sadeh LLP Is Investigating the Following Companies; Shareholders are Encouraged to Contact the Firm - AKCA, VRTU, IMMU, NTN

ACCESSWIRE IA September 22, 2020

Moore Kuehn Encourages RST, AKCA, DCOM, and SBPH Investors to Contact Law Firm

PR Newswire September 22, 2020

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Akcea Therapeutics, Inc. (Nasdaq -AKCA)

ACCESSWIRE IA September 21, 2020

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm - CBMG, AKCA, VRTU, IMMU

ACCESSWIRE IA September 21, 2020

STOCKHOLDER ALERT: Monteverde & Associates Reminds Shareholders of its Continuing Investigation Regarding the Merger

ACCESSWIRE IA September 20, 2020

ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm - AKCA, YIN, NGHC, OTEL

ACCESSWIRE IA September 17, 2020

Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., (NASDAQ:AIMT), Akcea Therapeutics, Inc., (NASDAQ:AKCA), BMC Stock Holdings, Inc., (NASDAQ:BMCH), and Cancer Genetics, Inc., (NASDAQ:CGIX)

GlobeNewswire September 16, 2020

SHAREHOLDER ALERT: Monteverde & Associates Continues Investigating the Merger

ACCESSWIRE IA September 16, 2020

SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Merger

ACCESSWIRE IA September 14, 2020

ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - AIMT, AKCA, PTI

ACCESSWIRE IA September 12, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA and AIMT Shareholders About Its Ongoing Investigations

PR Newswire September 11, 2020

Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., Akcea Therapeutics, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Broadway Financial Corporation, Cancer Genetics, Inc., Proteostasis Therapeutics, Inc., Rosetta Stone Inc., and Yintech Investment Holdings Limited

PR Newswire September 10, 2020